Skip to main content

Advertisement

Table 1 Predictors of Treatment among Patients with Hypertension, 2003 Guidelines

From: Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines

Variable Crude Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)†
Age   
≤50 1.00  
51–60 1.17 (0.70–1.96)  
61–70 1.47 (0.91–2.37)  
≥71 1.42 (0.88–2.28)  
Gender   
Male 1.00  
Female 1.26 (0.97–1.63)  
Diabetes   
Type I 1.55 (0.75–3.18)  
Type II 1.00  
Treatment *   
Diet 1.00 1.00
Oral meds 1.89 (1.31–2.74) 1.89 (1.31–2.74)
Insulin 1.04 (0.77–1.41) 1.04 (0.77–1.41)
Insulin + Oral 2.48 (1.13–5.43) 2.48 (1.13–5.43)
Kidney Disease **   
None 1.00  
Mild 1.32 (0.90–1.94)  
Moderate 0.97 (0.65–1.45)  
Severe 1.23 (0.34–4.50)  
Failure not valid  
Years Since Diagnosis   
≤5 1.00  
6–10 0.86 (0.62–1.19)  
≥11 1.32 (0.98–1.78)  
Years Since Referral   
≤3 1.00  
4–7 0.84 (0.61–1.17)  
≥8 0.94 (0.67–1.31)  
Weight (KG)   
≤55 1.00  
56–67 0.78 (0.35–1.71)  
68–90 0.87 (0.42–1.80)  
≥91 0.99 (0.47–2.06)  
  1. * Oral meds mean taking only oral antihyperglycemic medication; Insulin + Oral means patients who are taking insulin plus oral antihyperglycemic medication.
  2. ** Presence and stage of kidney disease as measured using the Cockroft-Gault formula.
  3. † Treatment was the only significant predictor, and therefore is not adjusted.